The College of American Pathologists and the Association of Molecular Pathology guidelines recommend EGFR, ALK and ROS1 gene tests as mandatory in non-small cell lung carcinoma(NSCLC) [3]. Here, EGFR is linked to non-small cell lung carcinoma.